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Summary Cancer patients undergoing radiotherapy frequently report fatigue. However, knowledge of the importance of fatigue for these
patients and of the factors associated with their fatigue is limited. The aim of the current investigation was to gain more insight into fatigue as
related to radiotherapy by answenng the following questions. First. how is the experience of fatigue best described? Secondly, to what extent
is fatigue related to sociodemographic, medical (including treatment), physical and psychological factors? Finally, is it possible to predict
which patients will suffer from fatigue after completion of radiotherapy? Patients with different types of cancer receiving radiotherapy with
curative intent (n = 250) were interviewed before and within 2 weeks of completion of radiotherapy. During treatment, patients rated their
fatigue at 2-weekly intervals. Results indicate a gradual increase in fatigue over the period of radiotherapy and a decrease after completion of
treatment. Fatigue scores obtained after radiotherapy were onty slightly, although significantly, higher than pretreatment scores. After
treatment, 46% of the patients reported fatigue among the three symptoms that caused them most distress. Significant associations were
found between post-treatment fatigue and diagnosis, physical distress, functional disability, quality of sleep, psychological distress and
depression. No association was found between fatigue and treatment or personality characteristics. Multivariate regression anatysis
demonstrated that the intensity of pretreatment fatigue was the best predictor of fatigue after treatment. In view of this finding, a regression
analysis was performed to gain more insight into the variables predicting pretreatmentfatigue. The degree offunctional disability and impaired
quality of sleep were found to explain 38% of the variance in fatigue before starting radiotherapy. Fatigue in disease-free patients 9 months
after treatment is described in paper (B) in this issue.
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In oncoloag. there is orowing awxareness that. wxith the dexelop-
ment of new treatment options the treatment burden for patients
max be increased. wxith little or no improxement in sur-ival.
Consequently. the patients appreciation of their quality of life
followxing treatment is more frequently taken into account along
,x-ith the more traditional outcomes of length of surnival and
morbiditV.
Symptom distress is an important component of patients
oxerall exaluation oftheir xxell-being (e.g. de Haes. 1988). Fatigue
is one of the common symptoms found to be negatively associated
wxith patients assessment of their quality of life (Aaronson et al.
1993: HUrriv et al. 1993). Yet. despite its apparent importance.
knowledge of the prexalence and correlates of fatigue is still
limited.
In patients receixing radiotherapy. fatigue or tiredness is
frequentlx reported. The experience of fatigue appears to be treat-
ment related. as reflected by differences in prexalence rates
between groups with different radiation fields. by a gradual
increase in fatigue ox er the course oftreatment and by- a reduction
in fatigue scores oxver wxeekends. x hen no treatment is gixen (King
et al. 1985: Greenberg et al. 1992: Irvine et al. 1994). Fatigue
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during radiotherapy may result directly from radiation. but max
also be an expression of the disease process or a residual effect of
prexvious treatment.
Phx-sical factors inxestigated to explain radiation-related fatigue
include haematocrit and haemoglobin (Greenberg et al. 1992:
Glaus. 1993: Irvine et al. 1994). wxeight and chanae in weight
(Haxlock and Hart. 1979: Greenberg et al. 1992: Glaus. 1993:
Irxine et al. 1994). serum interleukin 1 (IL-1I (Greenbera et al.
1993). reverse triiodothxronine and pulse change wxith orthostatic
stress (Greenberg et al. 1992). Except for change in weight
(Hay lock and Hart. 1979: I[rine et al. 1994). none of these factors
was found to be significantly associated with fatigue. The distress
associated with symptoms such as pain. nausea or sleep distur-
bances was found to be related to fatigue (Irnine et al. 1994).
So far. no studies haxe investigated the relation betwxeen
psychological factors and fatigue in radiation patients. Studies
investigating psychological distress in other cancer patients
suggest a relation betxxeen fatigue and depression and anxiety
(Nerenz et al. 1982: Fobair et al. 1986: Jamar. 1989: Blesh et al.
1991 ). This association miaht. in turn. be attributable to an associ-
ation of these emotions and fatigtue with personality characteris-
tics. such as neuroticism or optimism. A person's disposition may
be related to fatigue by influencing copina reactions. Optimists are
more likelyv to engaae in actixe attempts to cope xith a problem.
Persons xith a neurotic disposition are more likely to dxell upon
their negatixe experiences. employ axoiding strategies and disen-
aaae from actixve coping (Scheier and Carver. 1985). Disposition
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may also contribute to a person's tendency to self-monitor for
symptoms. Neurotic individuals are more sensitive to and likely
to report any bodily sensations. including fatigue (Hotopf and
Wessely. 1994).
The primary aim of this study was to come to a better under-
standing of fatigue in patients receiving radiotherapy. The
following questions guided the study. First, how can the experi-
ence of fatigue as related to radiotherapy be described? Secondly.
to what degree is fatigue related to sociodemographic, medical
(including treatment). physical and psychological factors? Finally,
is it possible to predict who will suffer most from fatigue after
completion ofradiotherapy?
METHOD
Sample and data collection procedure
Cancer patients attending for radiotherapy treatment at the
Academic Medical Centre in Amsterdam were approached.
Eligible patients were aged 18 years or older. receiving treatment
on an outpatient basis for cure or control of cancer rather than for
palliation. free of malignancy in the central nervous system. not
receiving chemotherapy and native Dutch.
The radiation oncologist introduced the study at the first consul-
tation with written information describing the purpose and
procedure of the investigation. Patients were later contacted by
telephone by the researchers to ask forconsent. Ofthe 308 eligible
patients. 250 (81%) agreed to participate. Patients who declined
participation were requested to rate the fatigue they experienced
during the previous week. as a check for bias in the study sample.
Participants were interviewed at their homes approximately 2
weeks before the start of treatment and 2 weeks after completion
of treatment. During the period of treatment. patients rated their
fatigue at 2-weekly intervals.
Instruments
Diagnosis. Karnofsky score. weight at the start of treatment and
treatment variables including dose, fractionation and radiation
area were obtained from the patients' medical records. Levels of
haemoglobin or haematocrit outside the normal range were
recorded over the period of treatment. The patients' prognosis in
terms of 5-year survival probability was classified by the Dutch
Cancer Registration Office as either less than 20%. 20-40%,
40-60%, 60-80% or greater than 80%.
The following data were collected on interview: medical
history. frequency offatigue (never. hardly ever. sometimes, most
ofthe time or always). the time of most intense fatigue during the
day (no clear pattem. early morning. noon, afternoon, late after-
noon. evening or depending upon time of radiation), physical
sensations associated with fatigue (muscle weakness. sweating.
uncomfortable feeling in the chest. sore muscles. blurred sight and
shortness of breath: with response categories not at all, a bit.
moderate and very much). less fatigue on days without radiation
(yes. no. don't know) and hours of sleep. At the post-treatment
interview, patients were asked to compare their present degree of
fatigue with fatigue before the start oftreatment (more fatigue. the
same. less fatigue).
In both the pre- and post-treatment interview, the following
instruments were used to assess fatigue in two ways. Firstly. The
Multidimensional Fatigue Inventory (MFI-20) was used. which is
a self-report instrument consisting offive scales based on different
modes of expressing fatigue. 'General fatigue' includes general
statements concerning a person's functioning such as I feel fit'.
'Physical fatigue' refers to the physical sensation related to the
feeling oftiredness. Possible somatic symptoms offatigue such as
light-headedness or sore muscles are not included in this scale in
order to exclude as much possible contamination with the symp-
toms of somatic illness, independent of fatigue. Reduction in
activities and lack of motivation to start any activity are covered
by the scales 'reduced activity' and 'reduced motivation' respec-
tively. Each scale contains four items. with a five-point response
format. Finally. cognitive symptoms such as having difficulties
concentrating are included in the scale for 'mental fatigue' (Smets
et al. 1995). Secondly. a single numerical rating scale ranging from
O (not tired at all) to 10 (worst tiredness imaginable), was used.
both in the interviews and for the 2-weekly assessment offatigue.
Similar numerical rating scales were used to assess the patient's
global assessment of his or her quality of life and the intensity
ofpain.
Functional disability was assessed by the Activities of Daily
Living Questionnaire (Picavet et al, 1992). extended to cover
habitual activities that may require effort but are not essential for
self-care. including physical exercise, household activities. social
activities, work related activities and mental activities.
Quality of sleep was measured using the general version of the
Groningen Sleep Quality Scale (Meijman et al. 1988). Physical
and psychological distress were assessed with the Rotterdam
Symptom Checklist (RSCL; de Haes et al. 1990).
Depression was measured using The Centre for Epidemiologic
Studies Depression Scale (CES-D: Radlof. 1977).
Finally. for the assessment of neuroticism and optimism the
shortened version of the Dutch Personality Questionnaire
(Jongerius, 1984) and the Life Orientation Test (LOT: Scheier and
Carver, 1985) were used respectively. In contrast to the other
instruments. these personality characteristics were only assessed
before treatment.
Stafial men ods
The MFI scale of general fatigue was used as the dependent vari-
able in all analyses involving associations with or prediction of
fatigue. Hereafter, general fatigue is referred to as 'fatigue'. The
scale for general fatigue was preferred over the use ofthe numer-
ical rating scale because of its more favourable psychometric
properties (Smets et al, 1995,1 996).
Paired t-tests were applied to test for changes in MFI fatigue
scores over the period of radiotherapy treatment. The 2-weekly
data from the numerical rating scale were subjected to MANOVA
analyses for repeated measures.
To investigate bivariate associations. Pearson correlation coeffi-
cients or analyses of variance were used. For the prediction of
post-treatment fatigue stepwise regression analyses were
performed. The predictor variables were grouped to cover the
following domains: sociodemographical. medical. treatment-
related. physical and psychological. For each of these domains. a
separate stepwise regression analysis was performed. Only predic-
tors explaining a significant amount ofthe variance in fatigue were
included in an overall regression analysis. Variables measured at
nominal level. such as diagnosis. were entered as binary (yes/no)
variables in the regression analyses.
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Plausible interactions. particularlv involving variables for w-hich
no initial bivariate association V ith fatigue x-as found. w-ere
explored using scattergrams and partial correlations.
In order to avoid spurious associations between fatigue. depres-
sion and physical distress. because of similaritn in item content.
analyses w-ere performed without overlapping items.
The associations between fatigue on the one hand and treatment
dose and fractionation on the other wvere assessed for patients Aho
received radiation at one target area only (n = 198) because too fewa
patients were radiated at two or more areas for statistical anal rses.
The relationships were determined separately for patients radiated
on the head and neck (n = 24). thorax (n = 71 ) and abdomen/pelvis
In = 118).
RESULTS
The sample
In Table 1. sociodemographic and medical information for the 250
participating patients is presented. Fourteen patients (6%7) who
s-ere not axailable for pretreatment assessment agreed to complete
the subsequent assessments. Of the 578 forms that wxere sent out
for the 2-weeklv assessment. 21 (4%c) A-ere not returned. After
treatment. 216 of the original 250 patients (86%/c) were still on
study: nine patients (4%7) had declined further participation and 25
patients (10%7) were not included in the second assessment for
medical reasons such as receivin5y additional chemotherapy or
because they could not be interviewed within the time limit of 1
month after treatment.
Patients A-ho declined considered participation to be emotion-
allv disturbin (100%). were too tired (5%7c) or too busy (9%s.
resented being interviewed at home (10%09c) or reported other
reasons: 25%7 gave no reason.
Non-participants (19%7) A-ere found to be older (69.5 vs 64 year:
t = -2.98. d.f. = 288. P < 0.005) and to have higher numerical
fatigue scores (mean 4.7. s.d. 3.0) than participants (mean 3.6.
s.d. 2.9: t = -1.98. d.f. = 263. P < 0.05). No differences were
found with respect to gender distribution.
Course and description of fatigue
Fatigue over the course of treatment
Table 2 contains the average pre- and post-treatment scores on the
MFI subscales. General fatigue scores increased significantly over
treatment (t = -2.54. d.f. = 199. P < 0.05). whereas mental fatigyue
tended to decrease (t = 1.90. d.f. = 200. P = 0.059). No significant
differences were found for the other three scales.
In Fiaure 1 the course of fatigue over the time of treatment is
shown for patients with a treatment period of 2-4 weeks. 4-6
xweeks or 6-8 weeks respectively. These data from the numerical
rating scale demonstrate an increase in fatigue over the course of
treatment and a decline after finishing, treatment. independent of
the duration of treatment. MANOVAs indicated these chanaes to
be significant for all three groups (group 1. F(3. 25) = 39. 19.
P<0.001: group 2. F(4.55)=56.70. P<0.001: group 3.
F(5.97) = 54.87. P < 0.001)
Post-treatment description of the fatigue experience
During the period of treatment. 405% of all patients reported being,
tired most of the time. 339% were sometimes and 27% hardly ever
tired. When comparingc their post-treatment level of fatigue with
Table 1 Sample characteristics (n = 250)
Mean age 64 years--13
Mean time since diagnosis 5.5 months 3
Range of
n % total
radiation
dose (Gy)
Gender Female 103 42
Male 147 58
Education level Less than high school 53 23
Lower educational level 80 34
High school 62 26
Advanced graduate degrees 41 17
Marital status Married 185 74
Living together 13 5
Single 22 9
Widowed 29 12
Diagnosis Head and neck 15 6 60-66
Gastrointestinal 13 6 45-60
Gynaecological 31 12 40-70
Lung 26 10 50-60
Breast 47 19 50-75
Prostate 64 26 60-70
Testis 7 3 26
Other genitourinary tract 22 9 40-70
Haematological malignancies 18 7 40
Miscellaneous 6 2 40-70
Kamofsky score 50 2 1
60 2 1
70 5 2
80 33 13
90 84 34
100 106 42
Frve-year survival <200o 27 11
probability 20-400 17 7
40-60% 29 12
60-8000 76 30
>80o 53 21
Co-morbidity 123 52
aVariatin in dose schemes within the tumour groups is due to variations in
indications: e.g. post-operative adjuvant vs primary radiotherapeutic
treatmnent.
fatigue before treatment. 447c of the patients reported an increase.
26% a decrease and 30%c no change. Percentages in the remainder
of this section are based on the 166 patients who had post-treat-
ment fatigyue scores greater than 1 on the numerical rating, scale.
The time of most intense fatigue was shortly after their dailv radi-
ation treatment for20% ofpatients. whereas 37% reported no clear
pattern. For all other responses related to timing. percentages w-ere
less than 15%c each. Twenty-eight per cent of patients reported
being less tired on days without radiation. Concerning associated
physical symptoms. shortness of breath and sweating, were both
reported by 29% of the patients (the response options 'a bit'.
bmoderate' and 'verv much' combined). muscle weakness bN 20%.
muscle soreness by 19%. uncomfortable feeling at the chest bs
16%7c and blurred vision bv 13%.
After treatment. 29% ofpatients rated theirfatigue on the RSCL
as moderate' and 17% as erv much'. For 46%c. fatigue was
reported as one of the three symptoms that caused them most
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Table 2 Mean scores on the separate MFI scales at pre- and post-treatment (range for each scale: 4-20)
Pretrea tent (n = 230) Post-treatment (n = 216)
Mean s.d. Mean s.d.
General fatigue 11.00 5.70 11.68a 5.86
Physical fatigue 11.15 4.92 11.71 5.25
Reduced activity 11.93 5.11 11.69 5.25
Reduced motivation 8.83 4.77 8.73 4.80
Mental fatigue 8.30 4.87 7.55 4.82
aSignificant difference compared with pretreatment. P < 0.05.
Ofthe indicators ofphysical functioning. weight before startinc
treatment and measures for anaemia were unrelated to fatigue
scores. The total degree of symptom distress proved to be associ-
ated with fatigue. as did pain intensity. sleep disturbances. number
of hours of sleep at night and day-time napping. Finallv. the more
patients were impaired in their capacitx to perform daily actix ities.
the higher their fatigue scores.
Fatigue and psychological state A-ere related as follows: psycho-
logical distress in general and depression in particular wxere related to
post-treatment fatigue. whereas neuroticism and optimism wxere not.
Prediction of post-treatment fatigue
Results regarding, the prediction of post-treatment fatigue from
Tl Week 2 T2/week 4 T2/week 6 T2!week 8 patient characteristics at pretreatment and radiotherapy aspects are
presented in Table 4. None of the sociodemographic characteris-
,ourse of fatigue over the period of radiotherapy treatment. tics of patients (age. gender. education) predicted post-treatment
tigue scores (range 0-10). Ti. pretreatment assessment: fatiaue. Of the medical variables (diagnosis. prognosis and co-
tment assessment; group 1. 31 patients receiving 2-4 weeks of morbiditv). a diagnosis of lunc cancer explained 317c of the vani-
group 2. 74 patients receiving 4-6 weeks of radiotherapy: ac
Ipatients receiving 6-8 weeks of radiotherapy. The bars indicate ance in post-treatment fatigue scores. Of the radiation treatment
the lines 1 standard deviation. S. Group 1: , group 2: variables (total radiation dose and number of fractions). the total
radiation dose explained 2%'S of the -ariance in post-treatment
fatigue.
For the domain of physical predictors assessed pretreatment
io other symptom from the RSCL was reported with (weight. functional disabilitv. sleep. physical distress. pain and
h prevalence. Fatigue correlated -0.46 IP < 0.001) with fatigue). the follow ing interactions were considered for inclusion
i's ox-erall quality of life. thus explainincg 21% of the in the regression analysis. It was assumed that. although prognosis
oxerall quality of life. and co-morbidity per se appeared to be unrelated to fatigtue. they
might interact with the degree of phNsical distress. Physical
distress in combination with an unfaxvourable prognosis. or with a associations with post-treatmentfatigue .. I co-morbidity. might explain an additional amount of the xvariance
e sociodemographic Xariableswxas found to be related to in post-treatment fatiaue. Indeed. the data suaaested that the asso-
nent fatigue (see Table 3). Ofthe medical variables. onil ciation between the degree ofphysical distress and post-treatment
was associated with fatigtue. Lung, cancer patients fatigue was different for the separate prognostic groups. There
ost (mean 15.0. s.d. 5.7) and patients with malignancies were no indications of a similar interaction Awith co-morbiditx.
Iand neckregion least (mean 10.5. s.d. 6.3) fatigue after Therefore. only the former interaction term was included in the
see Figure 2). Paired t-tests were performed for the four analysis. In addition. itw-as hypothesized thatphysical distress and
gnostic groups (gynaecological cancer. lung cancer. functional disability would be differently associated with fatiaue.
icer and urogenital malignancies) and a significant depending, on the patient's age. However. there was no evidence
as found for the group ofpatients with urogenital malig- supporting the latter hypothesis and therefore the interaction with
ly (t = -3.09. d.f. = 77. P <0.005). are was not included in the regression analysis. From the analysis.
ionships were found between post-treatment fatigue and fatigue before the start of radiotherapy proxed to be the best
ierapy characteristics of radiation dose or fractionation. predictor. explaininga 27'% of the variance in post-treatment
lifference emerged in post-treatment fatiaue between fatigue. None of the other -ariables in this domain. including, the
th breast cancer w-ho did (n = 15: mean 11.0. s.d. 6.2) or interaction term. improved the prediction. The same analysis. with
= 24: mean 11.8. s.d. 5.7) receixve treatment with pretreatment fatiaue excluded. resulted in 7%7 of the variance
apy. being explained by the patients' degree of functional disabilitv.
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Table 3 Bivariate associations of the vanous vanables with post-treament
general fatigue scores using Pearson product moment correlatons (r) or
analyses of variance (F)
Post-btatment fatigue
Domains and their variables Statstics P
Socioderographical
Sexa F(1 214) = 1.80 NS
Agea r=-0.08 NS
Educationa F(3. 144) = 0.10 NS
Medical
Diagnosisa F(6. 203) = 2.16 <0.05
Prognosisa r= - 0.13 NS
Co-morbidrtya F(1. 199) = 0.23 NS
Radiotherapy
Dose: r= -0.23. -0.25, -0.042 NS
Fractionations, r= -0.05.- 0.29, _0.03e NS
Brachytherapy FR1,37) =0.16 NS
Physical
Physical distress: r= 0.53 <0.001
Pain: r= 0.36 <0.001
Quality of sleep: r= 0.41 <0.001
Hours of sleepW r= 0.26 <0.001
Day-time nappingT F1, 214) = 22.82 <0.001
Weighta r= 0.01 NS
Haemoglobinc F(1 191) = 0.39 NS
Haematocrit: F(1, 190) = 0.01 NS
Functional disability: r= 0.60 <0.001
Psychological
Psychological distress: r= 0.37 <0.001
Depression: r= 0.43 <0.001
Optimisma r= -0.08 NS
Neuroticisma r= 0.08 NS
NS, not significant. aAssessed before radiotherapy. 'Assessed after
radiotherapy. :Assessed during radiotherapy. ,For patients radiated on the
head and neck (n = 24), thorax (n = 71) and abdomen/pelvis (n = 118)
respectivety. In each of the analyses the degrees of freedom vary slightly
because of listwise deletin.
Regarding the psychological vaniables (neuroticism. optimism.
psychological distress and depression) it was assumed that neuroti-
cism and optimism might be associated with fatigue in a different
xxav for men and w%omen. In addition. it was hypothesized that
disposition might interact with the degree of physical distress.
functional disability or reported quality of sleep. Howxever. prior
exploration yielded no evidence to justify the inclusion of these
interaction terms in the analysis. The analysis for this domain
showed psychological distress to explain 5% of the variance in
fatioue after treatment.
As a result of the foregoing analyses by domain. a subsequent
oxerall analysis included a diagnosis oflung cancer. the degree of
pretreatment fatigue and psychological distress and the total radia-
tion dose. Thirty-one per cent of the xariance in post-treatment
fatigue was found to be explained by pretreatment fatigue only.
A second analysis was performed. with pretreatment fatigue
excluded. Of the variance after treatment. 17% was explained by
the patients functional disabilitv at pretreatment assessment and
the diagnosis oflunc cancer.
Prediction of pretreatment fatigue
As a result of the foreaoina analvses. it became apparent that
pretreatment fatigue is the single best predictor of the degree of
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Figure 2 Mean pre- and post-treatment general fatigue scores for the
various diagnostic subgroups (range 4-20) The bars indicate mean scores.
the lines 1 standard deviatin. *, Pretreatment; El post-treatment
fatigue after treatment. In vie%v of this. it became of interest to
investigate which factors contribute to pretreatment fatigue.
Therefore. similar regression analyses were performed. now
usingy pretreatment fatigue as dependent v-ariable. Results are
presented in Table 5.
The domain-specific analyses indicated the following factors as
beingarelated tohigherpretreatmentfatigaue: beincg female. nothav-ing
a diagnosis of urogenital cancer. a higher degree of functional
disability andphysical distress. impairedquality ofsleep and ahigher
degree ofdepression. When combined in one analysis the degree of
functional disability and impaired quality of sleep remained signifi-
cantpredictors. explaining 38% ofthe Xariance in fatigue.
DISCUSSION
Two xweeks after the end of radiotherapy treatment 40% of the
patients reported havsina been almost continuously tired duringc the
treatment period. 44% reported that fatigue had increased oxer this
period and fatigue was among the three most distressing symptoms
for almost half of these patients. In addition. fatigue w-as found to
explain 21%7 of patients overall rating of their post-treatment
quality oflife. This is a considerable amount ofvariance explained
by a single symptom. Together. these findings illustrate the impor-
tance of fatigue for patients. As a consequence. they indicate that
fatigue deserves attention in radiotherapy treatment.
The prevalence and impact offatigue as found in this inxestiga-
tion may underestimate the actual problem. The differences in age
and fatigue between participants and non-participants suggest a
selection bias. with the older and more tired patients being, more
inclined to refuse participation. Another potential source oferror is
bias as a result ofloss to follow-up. Although attrition between the
two assessment points was small (14%). it involved mostly
patients with complications of their disease or treatment.
The gradual increase in fatigue oxer the course of treatment.
follow7ed by a decrease after ending treatment as demonstrated in
Figure 1. suggests an acute effect ofradiotherapy on fatigue. This
finding is in line with results reported by others (King et al. 1985:
Greenberg et al. 1992: Irvine et al. 1994). Other indicators of an
acute radiation effect are the weekend effect reported by 28% of
the patients. and the findinc that 20% reported fatigue to haxe been
most intense shortlv after being radiated.
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Table 4 Significant pretreatment predictors of post-treatment general fatigue scores. using stepwise regression analyses
Domain Predictor R RI Regression coefficient
B s.e.B P
1. Medical Lung cancer 0.18 0.03 3.57 1.36 <0.01
2. Radiation treatment Total dose 0.15 0.02 -0.04 0.02 <0.05
3. Physical Pretreatment fatigue 0.52 0.27 0.53 0.08 <0.0001
3a. Physical without pre-treatment fatigue Functional disability 0.27 0.07 0.17 0.06 <0.005
4. Psychological Psychological distress 0.23 0.05 0.35 0.11 <0.01
Combined (1.2.3.4) Pretreatment fatigue 0.56 0.31 0.57 0.06 <0.0001
Combined without pretreatment fatigue Functonal disability 0.38 0.15 0.22 0.04 <0.0001
(1.2.3a.4) Lung cancer 0.03 0.02 3.34 1.66 <0.05
Table 5 Significant pretreatment predictors of pretreatment general fatigue scores. using stepwise regression analyses
Domain Predictor R RRegression coefficient
B s.e.B P
Sociodemographic Gender 0.21 0.04 2.37 0.75 <0.005
Medical Urogenital cancer 0.25 0.06 -2.85 0.80 <0.0005
Physical Funconal disability 0.57 0.33 0.24 0.05 <0.0001
Sleep quality 0.06 0.07 0.43 0.13 <0.001
Physical distress 0.02 0.03 0.20 0.10 <0.05
Psychological Depression 0.35 0.12 0.36 0.07 <0.0001
Combined Functional disability 0.56 0 31 0.28 0.04 <0.0001
Sleep quality 0.06 0.07 0.50 0 11 <0.0001
In viex- ofthese indications of a radiation effect. it is somewhat
surprising that treatment characteristics such as radiation dose and
fractionation were almost unrelated to fatigue. A similar result has
been reported by Irvine et al (1994). It should be noted. however.
that both studies involved very heterogeneous samples. In this
investigation. crude categorizations were used (e.g. radiation
target area: head and neck region. thorax and abdomen/pelvis( to
have large enouah aroups for meaningful statistical analyses.
Studies involving more homogeneous samples with respect to
diag,nosis and/or treatment. such as in clinical trials. might provide
more insichtful information on the role of specific radiotherapy
charactenrstics in fatil2ue.
Althouah an increase in aeneral fatigue scores is found over the
treatment period. the numerical fatigue scores (Figure 1) showed a
lack of difference between pre- and post-treatment. This discrep-
ancv indicates that the MFI scale for aeneral fatioue is more sensi-
tixe in detecting, change oxer time than the single numerical scale.
It also sugaests that. although significant. the difference in fatiglue
between the two moments of assessment is small. At two weeks
after completion of radiotherapy. fatigue has already decreased to
a level only sliahtlv hiaher than before the start oftreatment.
The lack of more substantial differences in fatioue before and
afterradiotherapy does not. however. exclude a radiation treatment
effect. One w-ould have expected fatigue to decline after initial
treatment. mostly surgerx. ifnot followed byradiotherapy. Instead.
fatigue increased for the aroup as a whole. suggesting that radio-
therapy at least postpones the process of recovery for some
patients.
It also deserves mentioning that both pre- and post-treatment
scores x ere significantl7 higher than MFI fatigue scores from a
random sample from the Dutch general population (n = 139):
[mean fatigaue score = 9.91 (s.d. 5.2): difference with patients
pretreatment fatigue: F(360.1) = 5.24. P < 0.05: difference with
post-treatment fatigue: F(346.W1 = 15.52. P < 0.001W: (for more
detailed information. see follow-ing paper].
An important question addressed in this studv inxolved the
factors associated with fatigue. Bivariate associations were
assessed first. yieldina multiple associations with both medical.
physical and psycholoaical variables. The direction of these asso-
ciations is not alwavs straightforward. For example. an impaired
quality ofsleep is most likely to lead to more fatigue. which causes
a person to spend more time in bed. This. in tur. migcht aagrax ate
the sleeping problems. Other associations may indicate that
fatigue increases the burden induced bv other symptoms.
contributes to impaired performance ofdaily activities and causes
a person to feel anxious or depressed. However. converse relations
are also possible.
The association with diagnosis indicates that patients from
different diagnostic subgroups differ significantly in the degree of
post-treatment fatigue. Cancer of the lungs causes a person to feel
more fatigued than cancer in the head and neck region. The results
with respect to the diagnostic subgroups. as presented in Figure 2.
should be interpreted x ith reser ation. because of the small
numbers involhed. They seem to indicate that the increase in
fatigue scores oxer treatment might be ascribed primarily to
patients with gynaecological cancer. lung cancer. uro-genital
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cancer and haematological malignancies. Patients with cancer in
the head and neck region or breast seem to improve over the
course oftreatment.
The subsequent prediction of post-treatment fatigue. usingr a
prospective perspective. permits assumptions about the direction
of the relationships identified. Regarding the prediction of post-
treatment fatigue. the degree of fatigue before start of treatment
was more powerful than any other indicator of the physical condi-
tion of the patient in predicting post-treatment fatigue. explaining
27%c of the variance in post-treatment fatigue. If the degree of
pretreatment fatigue was not taken into consideration. the amount
of variance explained decreased substantially to 7%7c. Factors such
as functional disability. impaired sleep quality and the degree of
physical distress apparently do not contribute directly to the
prediction of post-treatment fatigue. However. in combination.
thev were found to explain 43%- of the variance in fatigue before
startinL treatment. As such. these variables are relevant for the
understanding offatigue both before and after treatment.
Of the psychological factors. depression was expected to
explain most of the variance in post-treatment fatigue. However.
the degree of psychological distress before starting treatment
proved to be the only significant predictor of post-treatment
fatigue. This suggests that feelings of anxietv and tension. as
included in the RSCL scale for psychological distress. also
contribute to fatigue. The total lack of an association between
fatigue and a patient's personality in terms of the degree of
neuroticism or optimism was unexpected. This findinc suggests
that fatigue reported by these patients cannot be considered to
result from stable psychological traits such as a general tendency
to complain.
WAhen combining all relevant -ariables in one analysis. pretreat-
ment fatigue proved to be the single most important predictor.
explaininc 31c% ofthe variance in post-treatment fatirue. This still
leaves a considerable amount ofthe variance in fatigue after radio-
therapy unexplained. It appears that. durinc the course of treat-
ment. factors not vet important before treatment start to contribute
to the experience of fatigue. The degree of physical distress was
found to increase sianificantlv over the course of radiotherapy
treatment [t 181) = -5.53. P < 0.001]. pointing to an increase in
symptoms other than fatigue. It is likely that the amount of
symptom distress developing as an acute effect of radiation would
explain an additional amount ofv-ariance in fatigue scores.
Effective treatment offatigue is still largely unknown. However.
some suggestions can be made. Fatigue in these patients seems to
result from the acute physical and psychological stress associated
with cancer and its treatment. Consequentl,. extra care taken in the
amelioration of other symptomatologv. both somatic and psycho-
locrical. is a means of treating fatigue. The associations found
suggest that interventions aimed at reducinc psychological distress
may have a beneficial effect on fatigue. An evaluation of the
results of 22 studies investigating the effect ofpsychological treat-
ment on cancer patients resulted in the conclusion that - amonLt
other things - tailored counselling was indeed effective with
respect to fatigue (Trijsburg et al. 1992). Asking patients before
they start their course ofradiotherapy treatment about the intensity
oftheir fatigue may be an easy and effective way to identifv those
patients who are likeely to continue to experience fat]iue durinc,
and after treatment. These patients max then be informed accord-
ingly. Results have indicated that patients do not always expect
fatigue to be a side-effect of treatment (Cassileth et al. 1985: Love
et al. 1989: Tierney et al. 1991). Preparatory information on what
to expect in terms of fatigue during and after treatment could
enhance the possibility of patients to cope with this symptom.
Phy-sical activity training has frequently been referred to as an
intervention with possible beneficial effects on fatigue. However.
its effectiveness has been tested in small studies only (Questad.
1983: McVicar and Winningham. 1984: Young and Sexton. 1991).
The strong associations found in this investigation between fatigue
and functional disabilitv. with the latter predicting fatigue over
time. lends support to the hypothesis that overcoming functional
disability. for example with exercise. may lead to a reduction in
fatigue. Research investigating the effectiveness of different inter-
ventions to reduce fatigue is urgently needed.
Finally. although the results of this and other studies indicate a
decrease in fatigue in the first weeks following completion of
radiotherapy. further research should address the course fatigue
takes afterw-ards. Enhanced understanding offatigue and develop-
ment of effective interventions has the potential to improxve
patients quality of life.
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